Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Good News: First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy
Celebrating faculty and staff achievements
Internal pressure makes pancreatic tumors hard to treat
The blood vessel-crushing, chemo-blocking pressure inside pancreatic tumors is almost entirely due to water trapped in gel form, study shows
Cancer deaths drop overall, but now top cause in many states
Early detection, better treatments contributed to 23 percent decline in two decades, report shows
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Immunotherapy for pancreatic cancer boosts survival by more than 75% in mice
Human trials are planned within the next year
New treatment doubles progression-free survival in some pancreatic cancer patients
Enzyme lowers pressure inside tumors, allows chemotherapy in
Researchers discover tumor molecule that causes spread of pancreatic cancer
Testing could help guide treatment
PBS filmmaker: ‘We’re at a threshold moment’
‘Emperor of All Maladies’ director, Hutch researchers and a cancer survivor preview the upcoming cancer documentary
Sorting out the truth about aspirin
Aspirin may cut pancreatic cancer risk, but should everyone take it?